Hindman JT

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hindman

Contact Hindman, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials

May 18, 2023 |

By Arribas JR, Sax PE, Stellbrink HJ, Hindman JT

| ncbi.nlm.nih.gov

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

Open in Who Shared View Duplicates (593)

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Hindman

Contact Hindman, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Overview

Use Cases

Capabilities

Industries

Library

Commmunity

Customers

Hindman JT

Get in touch with Hindman

Actions

Is this you?

Articles

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials

Actions

Is this you?

Get in touch with Hindman